Browse diseases

… a cornerstone of cardiac rehabilitation and is recommended for coronary artery disease (CAD) and chronic heart failure (CHF) patients.1 Participation …

… and multifactorial, involving mechanisms such as hypertension, coronary artery disease, left ventricular dysfunction, right ventricular impairment, sy…

…al anticoagulants (DOACs) on clinical outcomes in patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) remains unclear.M…

…AD), potentially mitigating progression to symptomatic disease. Systemic lupus erythematosus (SLE) has an increased risk of accelerated atherosclerotic CAD.…

…Objectives Type I-III interferons (IFNs) are key mediators in systemic lupus erythematosus (SLE) and have been proposed to contribute to cardiovascular di…

… rheumatologists from the hospital’s electronic records system. SLE patients who met the 1990 American College of Rheumatology (ACR…

…In patients with coronary artery disease (CAD), percutaneous coronary intervention (PCI) is indicated in…

…tress testing (EST) is commonly used for risk stratification in coronary artery disease (CAD), it yields inconclusive results in up to 20% of patients.…

…Background Chronic kidney disease is common in patients with coronary artery disease (CAD) and ca…

…nti-platelet therapy remains a cornerstone of the treatment for coronary artery disease. When choosing a second anti-platelet, ticagrelor remains a pri…

…. Her medical history was significant for diabetes mellitus and coronary artery disease. There was no history of prolonged fasting, any recent diuretic…

…Coronary artery disease (CAD) is a leading cause of global morbidity and mortality.1 In…